<?xml version="1.0" encoding="UTF-8"?>
<ClinicalDocument xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <realmCode code="US"/>
  <typeId root="2.16.840.1.113883.1.3" extension="POCD_HD000040"/>
  <templateId root="2.16.840.1.113883.10.20.22.1.1" extension="2015-08-01"/>
  <templateId root="2.16.840.1.113883.10.20.22.1.4" extension="2015-08-01"/>
  <id root="ec3adebb-5b1c-4ded-8470-c5c62cd7b70e"/>
  <code code="11488-4" codeSystem="2.16.840.1.113883.6.1" codeSystemName="LOINC" displayName="Consult note"/>
  <title>SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Medical Oncology (genitourinary) Consultation — Pablo Neruda</title>
  <effectiveTime value="20260615120000-0500"/>
  <confidentialityCode code="N" codeSystem="2.16.840.1.113883.5.25"/>
  <languageCode code="en-US"/>
  <setId root="9bf2825a-2ad1-4838-8b7e-3f717a2f2c0d"/>
  <versionNumber value="1"/>
  <recordTarget>
    <patientRole>
      <id root="99c79178-214d-4693-8243-e7dcc8c23f68" extension="HR-ML051-SYN"/>
      <id root="2.16.840.1.113883.4.1" extension="000-51-2976"/>
      <addr nullFlavor="UNK"/>
      <telecom nullFlavor="UNK"/>
      <patient>
        <name use="L"><given>Pablo</given><family>Neruda</family></name>
        <administrativeGenderCode code="M" codeSystem="2.16.840.1.113883.5.1" displayName="Male"/>
        <birthTime value="19590712"/>
        <raceCode nullFlavor="ASKU"/>
        <ethnicGroupCode nullFlavor="ASKU"/>
        <languageCommunication><languageCode code="en"/><preferenceInd value="true"/></languageCommunication>
      </patient>
      <providerOrganization>
        <id root="6a7f851b-842b-45d7-9552-3e8582647414"/>
        <name>St. Posthumous Health Center</name>
      <telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr>
      </providerOrganization>
    </patientRole>
  </recordTarget>
  <author>
    <time value="20260615120000-0500"/>
    <assignedAuthor><id root="2fad8961-b352-4d57-9129-3124c2b08e5a"/><addr nullFlavor="UNK"/><telecom nullFlavor="UNK"/><assignedPerson><name><given>Étienne</given><family>Okonkwo-Lund</family><suffix>MD</suffix></name></assignedPerson><representedOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedOrganization></assignedAuthor>
  </author>
  <custodian>
    <assignedCustodian><representedCustodianOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedCustodianOrganization></assignedCustodian>
  </custodian>
  <legalAuthenticator>
    <time value="20260615120000-0500"/>
    <signatureCode code="S"/>
    <assignedEntity><id root="2fad8961-b352-4d57-9129-3124c2b08e5a"/><addr nullFlavor="UNK"/><telecom nullFlavor="UNK"/><assignedPerson><name><given>Étienne</given><family>Okonkwo-Lund</family><suffix>MD</suffix></name></assignedPerson><representedOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedOrganization></assignedEntity>
  </legalAuthenticator>
  <inFulfillmentOf>
    <order><id root="e60e4f0c-aa2a-425b-a9c4-b111e51b3566"/></order>
  </inFulfillmentOf>
  <documentationOf>
    <serviceEvent classCode="PCPR"><effectiveTime><low value="20260615"/><high value="20260615"/></effectiveTime><performer typeCode="PRF"><assignedEntity><id root="2fad8961-b352-4d57-9129-3124c2b08e5a"/><addr nullFlavor="UNK"/><telecom nullFlavor="UNK"/><assignedPerson><name><given>Étienne</given><family>Okonkwo-Lund</family><suffix>MD</suffix></name></assignedPerson><representedOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedOrganization></assignedEntity></performer></serviceEvent>
  </documentationOf>
  <componentOf>
    <encompassingEncounter>
      <id root="ccbf1436-f719-4f35-9c51-df54ca1efaf5"/>
      <code code="390906007" codeSystem="2.16.840.1.113883.6.96" displayName="Follow-up encounter"><originalText>Two-week review with the medical oncology consultation the same day: biopsy and staging results, the diagnosis, shared decision on treatment, the start of apalutamide, genetic testing, and bone density</originalText></code>
      <effectiveTime><low value="20260615"/><high value="20260615"/></effectiveTime>
      <encounterParticipant typeCode="ATND"><assignedEntity><id root="2fad8961-b352-4d57-9129-3124c2b08e5a"/><addr nullFlavor="UNK"/><telecom nullFlavor="UNK"/><assignedPerson><name><given>Étienne</given><family>Okonkwo-Lund</family><suffix>MD</suffix></name></assignedPerson><representedOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedOrganization></assignedEntity></encounterParticipant>
      <location><healthCareFacility><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><serviceProviderOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></serviceProviderOrganization></healthCareFacility></location>
    </encompassingEncounter>
  </componentOf>
  <component>
    <structuredBody>

<component>
  <section>
    <templateId root="1.3.6.1.4.1.19376.1.5.3.1.3.1" extension="2014-06-09"/>
    <code code="42349-1" codeSystem="2.16.840.1.113883.6.1" displayName="Reason for referral (narrative)"/>
    <title>Reason for Referral</title>
    <text><paragraph>Man of 66 with four months of urinary symptoms and six weeks of right hip and low back pain, a hard nodular prostate, PSA 46.8 ng/mL and a raised alkaline phosphatase: suspected metastatic prostate cancer. Please confirm the diagnosis and extent and advise on treatment, including bone health and genetic testing. [S]</paragraph><paragraph>Urgency: Urgent, within two weeks. [S]</paragraph><paragraph>Questions for the consultant:</paragraph><list listType="ordered"><item>Do the results confirm prostate cancer, and what is the extent and volume of disease?</item><item>Which systemic treatment do you recommend, and is docetaxel indicated?</item><item>Is radiotherapy to the prostate indicated?</item><item>How should bone health and the bone metastases be managed, including the need for a bone-protective drug and at what dose?</item><item>Should he have germline and tumor genetic testing?</item><item>How will the treatment interact with his amlodipine, and which monitoring should primary care carry out?</item></list></text>

  </section>
</component>

<component>
  <section>
    <templateId root="1.3.6.1.4.1.19376.1.5.3.1.3.4"/>
    <code code="10164-2" codeSystem="2.16.840.1.113883.6.1" displayName="History of Present illness Narrative"/>
    <title>History of Present Illness</title>
    <text><paragraph>Mr. Neruda is seen at the request of Dr. Fairweather-Diaz, with a professional Spanish interpreter, for suspected metastatic prostate cancer. He has had four months of urinary frequency, a weak stream and nocturia, and six weeks of right hip and low back pain, now 5 of 10 on acetaminophen. He has no leg weakness, numbness, or change in bladder or bowel control, and no weight loss. He has hypertension treated with amlodipine and no other illness. He never smoked. Beyond his mother&apos;s death shortly after his birth, he does not know his family&apos;s medical history. He is fully active apart from the hip pain (ECOG 1), writes every morning and carries a full schedule of official duties. He asked for a plain account of the results and of every option. [S]</paragraph><paragraph>Historical basis. These claims are historical evidence, not findings from a modern examination.</paragraph><list><item>Pablo Neruda was born on 12 July 1904 in the town of Parral in Chile. His father was a railway employee, and his mother, a teacher, died shortly after his birth; he spent his childhood and youth in Temuco. [D]</item><item>He used the pen name Pablo Neruda from 1920. The Nobel Prize biography gives his real name as Neftalí Ricardo Reyes Basoalto; the Library of the National Congress of Chile gives his birth name as Ricardo Eliecer Neftalí Reyes Basoalto and records that a court judgment of 28 December 1946 changed it to Pablo Neruda. [D]</item><item>Between 1927 and 1935 he held a series of honorary consulships in Burma, Ceylon, Java, Singapore, Buenos Aires, Barcelona and Madrid; in 1945 he was elected a senator of the Republic and joined the Communist Party of Chile. [D]</item><item>After the 1970 presidential election he was named Chile&apos;s ambassador to France; the Senate approved the appointment on 21 January 1971 and he presented his credentials at the end of that month. He resigned the post in 1972 and returned to Chile in November 1972. [D]</item></list><paragraph>9 later historical claims are omitted because they describe events after the index age. See the teaching note.</paragraph></text>

  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.6" extension="2015-08-01"/><templateId root="2.16.840.1.113883.10.20.22.2.6.1" extension="2015-08-01"/>
    <code code="48765-2" codeSystem="2.16.840.1.113883.6.1" displayName="Allergies and adverse reactions Document"/>
    <title>Allergies and Intolerances</title>
    <text><table><thead><tr><th>Allergy</th><th>Reaction</th><th>Status</th><th>Evidence</th></tr></thead><tbody><tr ID="allergy-1"><td>No known allergy</td><td></td><td>active</td><td>S</td></tr></tbody></table></text>

  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.30" extension="2015-08-01"/>
      <id root="1b33dad6-fc53-4bbc-bb2c-96498a1ca55b"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="20260601"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN" negationInd="true">
          <templateId root="2.16.840.1.113883.10.20.22.4.7" extension="2014-06-09"/>
          <id root="16799c55-09bf-4762-88f8-1754b5f60aba"/>
          <code code="ASSERTION" codeSystem="2.16.840.1.113883.5.4"/>
          <text><reference value="#allergy-1"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low nullFlavor="UNK"/></effectiveTime>
          <value xsi:type="CD" code="419199007" codeSystem="2.16.840.1.113883.6.96" displayName="Allergy to substance"/>
          <participant typeCode="CSM"><participantRole classCode="MANU"><playingEntity classCode="MMAT"><code nullFlavor="NA"/></playingEntity></participantRole></participant>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.1" extension="2014-06-09"/><templateId root="2.16.840.1.113883.10.20.22.2.1.1" extension="2014-06-09"/>
    <code code="10160-0" codeSystem="2.16.840.1.113883.6.1" displayName="History of Medication use Narrative"/>
    <title>Medications</title>
    <text><table><thead><tr><th>Medication</th><th>Frequency</th><th>Route</th><th>Dates</th><th>Status</th><th>Evidence</th></tr></thead><tbody><tr ID="medication-1"><td>Amlodipine 5 mg oral tablet, one tablet daily</td><td>One tablet daily</td><td>Oral route</td><td>2021-04-06 to 2026-07-13</td><td>completed</td><td>S</td></tr><tr ID="medication-3"><td>Acetaminophen 500 mg oral tablet, two tablets (1000 mg) up to three times daily as needed for bone pain</td><td>Two tablets up to three times daily as needed</td><td>Oral route</td><td>2026-06-01 to 2026-09-14</td><td>completed</td><td>S</td></tr><tr ID="medication-4"><td>Apalutamide 240 mg oral tablet, one tablet once daily, swallowed whole, with or without food</td><td>One tablet once daily</td><td>Oral route</td><td>2026-06-15</td><td>active</td><td>S</td></tr><tr ID="medication-6"><td>Cholecalciferol (vitamin D3) 2000 units (0.05 mg) oral tablet, one tablet daily</td><td>One tablet daily</td><td>Oral route</td><td>2026-06-15</td><td>active</td><td>S</td></tr></tbody></table></text>

  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="9730a304-4e84-4ee0-95ae-e3d57201e4de"/>
      <text><reference value="#medication-1"/></text>
      <statusCode code="completed"/>
      <effectiveTime xsi:type="IVL_TS"><low value="20210406"/><high value="20260713"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="1" unit="d"/></effectiveTime>
      <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Oral route"/>
      <doseQuantity value="1"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="197361" codeSystem="2.16.840.1.113883.6.88" displayName="amlodipine 5 MG Oral Tablet"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="03b78115-2bdf-496d-8ec0-b23f169187ab"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="I10" codeSystem="2.16.840.1.113883.6.90" displayName="Essential (primary) hypertension"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="9c9c6102-50a3-41a9-b24d-f7bf9c21354a"/>
      <text><reference value="#medication-3"/></text>
      <statusCode code="completed"/>
      <effectiveTime xsi:type="IVL_TS"><low value="20260601"/><high value="20260914"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="8" unit="h"/></effectiveTime>
      <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Oral route"/>
      <doseQuantity value="2"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="198440" codeSystem="2.16.840.1.113883.6.88" displayName="acetaminophen 500 MG Oral Tablet"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="b4588fdf-39bb-4955-957a-521a2b888623"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="R97.20" codeSystem="2.16.840.1.113883.6.90" displayName="Elevated prostate specific antigen [PSA]"/>
        </observation>
      </entryRelationship>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="fd8a77dc-4a0c-4536-93da-d3d235acba34"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="C79.51" codeSystem="2.16.840.1.113883.6.90" displayName="Secondary malignant neoplasm of bone"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="7c588d54-4c52-4d23-9b88-248b8bb1c2db"/>
      <text><reference value="#medication-4"/></text>
      <statusCode code="active"/>
      <effectiveTime xsi:type="IVL_TS"><low value="20260615"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="1" unit="d"/></effectiveTime>
      <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Oral route"/>
      <doseQuantity value="1"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="2630215" codeSystem="2.16.840.1.113883.6.88" displayName="apalutamide 240 MG Oral Tablet"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="113e638d-c0fb-4b64-af15-85f04dfa06e2"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="C61" codeSystem="2.16.840.1.113883.6.90" displayName="Malignant neoplasm of prostate"/>
        </observation>
      </entryRelationship>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="8df557ed-d9e3-4d13-bde0-d41d289d9304"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="Z19.1" codeSystem="2.16.840.1.113883.6.90" displayName="Hormone sensitive malignancy status"/>
        </observation>
      </entryRelationship>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="f39931f9-893b-4ae8-9724-8eb762d139cf"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="Z79.899" codeSystem="2.16.840.1.113883.6.90" displayName="Other long term (current) drug therapy"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="2cff4a50-2a6c-49dd-aff2-478b85c8abdf"/>
      <text><reference value="#medication-6"/></text>
      <statusCode code="active"/>
      <effectiveTime xsi:type="IVL_TS"><low value="20260615"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="1" unit="d"/></effectiveTime>
      <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Oral route"/>
      <doseQuantity value="1"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="801663" codeSystem="2.16.840.1.113883.6.88" displayName="cholecalciferol 0.05 MG Oral Tablet"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="984a35aa-324e-456a-be8a-0c28d4f17cda"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="E55.9" codeSystem="2.16.840.1.113883.6.90" displayName="Vitamin D deficiency, unspecified"/>
        </observation>
      </entryRelationship>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="5e74bd0b-bdf8-4e72-900a-1db3fc360faa"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="M85.89" codeSystem="2.16.840.1.113883.6.90" displayName="Other specified disorders of bone density and structure, multiple sites"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.5" extension="2015-08-01"/><templateId root="2.16.840.1.113883.10.20.22.2.5.1" extension="2015-08-01"/>
    <code code="11450-4" codeSystem="2.16.840.1.113883.6.1" displayName="Problem List"/>
    <title>Problems</title>
    <text><table><thead><tr><th>Problem</th><th>Clinical status</th><th>Verification</th><th>Code</th><th>Provenance</th></tr></thead><tbody>
  <tr ID="problem-1">
    <td>Urinary frequency, weak stream and nocturia for four months, with right hip and low back pain for six weeks, a hard nodular prostate and a raised PSA; suspected prostate cancer, to be confirmed</td><td>resolved</td><td>confirmed</td>
    <td>R97.20</td><td>S — Synthetic presenting problem, resolved at the second visit when biopsy and staging established metastatic prostate cancer.</td>
  </tr>
  <tr ID="problem-2">
    <td>Adenocarcinoma of the prostate, Grade Group 4 (Gleason 4+4), cT3a N1 M1b, de novo metastatic hormone-sensitive disease, low volume by conventional imaging (two bone metastases, in the right ilium and L5, and two pelvic lymph nodes; no visceral disease); synthetic modern detail linked to his documented prostate cancer of 1971</td><td>active</td><td>confirmed</td>
    <td>C61</td><td>S — Synthetic grade, stage, extent and PSA; the prostate cancer and the operation in France in 1971 are documented (D), and no stage, grade or treatment detail was found in the sources read.</td>
  </tr>
  <tr ID="problem-3">
    <td>Bone metastases from prostate cancer: right iliac wing (painful) and L5 vertebral body; no cord compression</td><td>active</td><td>confirmed</td>
    <td>C79.51</td><td>S — Synthetic metastatic sites.</td>
  </tr>
  <tr ID="problem-4">
    <td>Pelvic lymph node metastases: right external iliac and right obturator nodes</td><td>active</td><td>confirmed</td>
    <td>C77.5</td><td>S — Synthetic nodal disease.</td>
  </tr>
  <tr ID="problem-5">
    <td>Hormone-sensitive prostate cancer</td><td>active</td><td>confirmed</td>
    <td>Z19.1</td><td>S — Synthetic status in the modern episode.</td>
  </tr>
  <tr ID="problem-6">
    <td>Continuous androgen deprivation (leuprolide) with apalutamide, with monitoring of testosterone, PSA, thyroid function, blood pressure, glucose and lipids, bone health, rash, falls, hot flashes, sexual health, mood and cognition</td><td>active</td><td>confirmed</td>
    <td>Z79.899</td><td>S — Synthetic treatment plan; Z79.899 is used because ICD-10-CM has no specific code for GnRH agonist therapy.</td>
  </tr>
  <tr ID="problem-7">
    <td>Essential hypertension for five years, on amlodipine</td><td>active</td><td>confirmed</td>
    <td>I10</td><td>S — Synthetic comorbidity, relevant to cardiovascular risk on androgen deprivation; not a claim about his real blood pressure.</td>
  </tr>
  <tr ID="problem-8">
    <td>Vitamin D insufficiency (25-hydroxyvitamin D 22 ng/mL)</td><td>active</td><td>confirmed</td>
    <td>E55.9</td><td>S — Synthetic finding at intake, addressed at the second visit.</td>
  </tr>
  <tr ID="problem-9">
    <td>Low bone mass (femoral neck T-score -2.1, L1 to L4 -1.4) with a ten-year hip fracture risk above 3% (FRAX, with androgen deprivation counted as a cause of secondary osteoporosis)</td><td>active</td><td>confirmed</td>
    <td>M85.89</td><td>S — Synthetic bone-health finding on the DXA before androgen deprivation.</td>
  </tr>
  <tr ID="problem-10">
    <td>Prediabetes (hemoglobin A1c 5.9%)</td><td>active</td><td>confirmed</td>
    <td>R73.03</td><td>S — Synthetic metabolic finding at intake, relevant to androgen deprivation.</td>
  </tr></tbody></table></text>

  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="06213280-05b7-4a76-8360-f1e535e4f719"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="completed"/>
      <effectiveTime><low value="20260601"/><high value="20260615"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="5112a268-4540-48de-ab40-413567ee1ad7"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-1"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="20260601"/><high value="20260615"/></effectiveTime>
          <value xsi:type="CD" code="R97.20" codeSystem="2.16.840.1.113883.6.90" displayName="Elevated prostate specific antigen [PSA]"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="9ef1d279-23f7-4d71-b143-98f38f542f67"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="20260615"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="b755d6ed-cafd-466a-a5b8-df2289d7cb9e"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-2"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="20260615"/></effectiveTime>
          <value xsi:type="CD" code="C61" codeSystem="2.16.840.1.113883.6.90" displayName="Malignant neoplasm of prostate"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="7aa74503-110b-4e98-9d55-06da473749e1"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="20260615"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="bd8664aa-5b48-4cdb-a434-91a661ce58f4"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-3"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="20260615"/></effectiveTime>
          <value xsi:type="CD" code="C79.51" codeSystem="2.16.840.1.113883.6.90" displayName="Secondary malignant neoplasm of bone"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="986bc96b-beab-4736-9864-6a1cb53c29e2"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="20260615"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="8955d24d-f179-47b3-b2a5-0ea0e1d69e1d"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-4"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="20260615"/></effectiveTime>
          <value xsi:type="CD" code="C77.5" codeSystem="2.16.840.1.113883.6.90" displayName="Secondary and unspecified malignant neoplasm of intrapelvic lymph nodes"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="067c7dd9-edc4-42ad-95dc-81b34bab100f"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="20260615"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="10630a94-da0d-4a51-b37d-0a0298749465"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-5"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="20260615"/></effectiveTime>
          <value xsi:type="CD" code="Z19.1" codeSystem="2.16.840.1.113883.6.90" displayName="Hormone sensitive malignancy status"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="818def5c-cba2-4751-b1ae-9fe3884c0754"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="20260615"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="844e88e1-3f30-4dac-8c4d-e85d5d290528"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-6"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="20260615"/></effectiveTime>
          <value xsi:type="CD" code="Z79.899" codeSystem="2.16.840.1.113883.6.90" displayName="Other long term (current) drug therapy"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="0d487f33-5e29-4c4b-8202-5304a26040b5"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="20260601"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="958429b7-c197-4805-9f51-ba322e0c7581"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-7"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="20260601"/></effectiveTime>
          <value xsi:type="CD" code="I10" codeSystem="2.16.840.1.113883.6.90" displayName="Essential (primary) hypertension"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="78a78346-da33-4860-b6c8-454c53e16f0c"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="20260615"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="ec0b5de1-92d6-4853-89eb-870ec212e3dd"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-8"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="20260615"/></effectiveTime>
          <value xsi:type="CD" code="E55.9" codeSystem="2.16.840.1.113883.6.90" displayName="Vitamin D deficiency, unspecified"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="084b1bd6-b360-4e77-b379-c62ab3421e2d"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="20260615"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="f50ec7e7-216c-4abc-ab1d-5b875d300ef4"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-9"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="20260615"/></effectiveTime>
          <value xsi:type="CD" code="M85.89" codeSystem="2.16.840.1.113883.6.90" displayName="Other specified disorders of bone density and structure, multiple sites"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="87fb2c72-6e49-4338-a3c5-30da25963cfa"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="20260601"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="a019aac6-da29-49d7-b170-56aa3080dd23"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-10"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="20260601"/></effectiveTime>
          <value xsi:type="CD" code="R73.03" codeSystem="2.16.840.1.113883.6.90" displayName="Prediabetes"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.2.10" extension="2015-08-01"/>
    <code code="29545-1" codeSystem="2.16.840.1.113883.6.1" displayName="Physical findings note"/>
    <title>Physical Exam</title>
    <text><paragraph>Vital signs recorded on 2026-06-15; see the referring visit&apos;s Vital Signs section. [S]</paragraph><table><thead><tr><th>System</th><th>Finding</th></tr></thead><tbody><tr><td>General</td><td>Well; walks without help, favoring the right hip slightly; ECOG 1</td></tr><tr><td>Musculoskeletal</td><td>Tender over the right iliac crest; no midline spinal tenderness</td></tr><tr><td>Neurological</td><td>Strength 5 of 5 in both legs; sensation and reflexes normal</td></tr><tr><td>Lymph nodes</td><td>No inguinal or supraclavicular nodes</td></tr></tbody></table></text>

  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.3" extension="2015-08-01"/><templateId root="2.16.840.1.113883.10.20.22.2.3.1" extension="2015-08-01"/>
    <code code="30954-2" codeSystem="2.16.840.1.113883.6.1" displayName="Relevant Diagnostic Tests and/or Laboratory Data"/>
    <title>Results</title>
    <text><table><thead><tr><th>Date</th><th>Measure</th><th>Value</th><th>Unit</th><th>Reference range</th><th>Flag</th><th>Provenance</th></tr></thead><tbody>
  <tr ID="result-26"><td>2026-06-15</td><td>DXA Femur [T-score] Bone density</td><td>-2.1</td><td>{T-score}</td><td>-1.0 or higher is normal; -2.5 or lower is osteoporosis</td><td>Low</td><td>S</td></tr>
  <tr ID="result-27"><td>2026-06-15</td><td>DXA Lumbar spine [T-score] Bone density</td><td>-1.4</td><td>{T-score}</td><td>-1.0 or higher is normal; -2.5 or lower is osteoporosis</td><td>Low</td><td>S</td></tr>
  <tr ID="result-28"><td>2026-06-15</td><td>Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]</td><td>1</td><td>{score}</td><td></td><td></td><td>S</td></tr>
  <tr ID="result-29"><td>2026-06-15</td><td>Pain severity - 0-10 verbal numeric rating [Score] - Reported</td><td>5</td><td>{score}</td><td></td><td></td><td>S</td></tr></tbody></table></text>

  <entry typeCode="DRIV">
    <organizer classCode="CLUSTER" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.1" extension="2015-08-01"/>
      <id root="34533018-b7bd-4237-97ce-31417e2954a8"/>
      <code code="38263-0" codeSystem="2.16.840.1.113883.6.1" displayName="DXA Femur [T-score] Bone density"/>
      <statusCode code="completed"/>
      <effectiveTime><low value="20260615"/><high value="20260615"/></effectiveTime>

      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="1d45cc8e-d30a-45b1-851a-dd94cc87039d"/>
          <code code="38263-0" codeSystem="2.16.840.1.113883.6.1" displayName="DXA Femur [T-score] Bone density"/>
          <text><reference value="#result-26"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="20260615"/>
          <value xsi:type="PQ" value="-2.1" unit="{T-score}"/>
          <interpretationCode code="L" codeSystem="2.16.840.1.113883.5.83" displayName="Low"/>
          <referenceRange>
            <observationRange>
              <text>-1.0 or higher is normal; -2.5 or lower is osteoporosis</text>
              <value xsi:type="IVL_PQ"><low value="-1" unit="{T-score}"/></value>
            </observationRange>
          </referenceRange>
        </observation>
      </component>
    </organizer>
  </entry>
  <entry typeCode="DRIV">
    <organizer classCode="CLUSTER" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.1" extension="2015-08-01"/>
      <id root="f1afd9e6-652c-4c2e-8201-df7f6c2cac23"/>
      <code code="38267-1" codeSystem="2.16.840.1.113883.6.1" displayName="DXA Lumbar spine [T-score] Bone density"/>
      <statusCode code="completed"/>
      <effectiveTime><low value="20260615"/><high value="20260615"/></effectiveTime>

      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="bbf27c2c-7257-4487-b06c-d1b8af0a5487"/>
          <code code="38267-1" codeSystem="2.16.840.1.113883.6.1" displayName="DXA Lumbar spine [T-score] Bone density"/>
          <text><reference value="#result-27"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="20260615"/>
          <value xsi:type="PQ" value="-1.4" unit="{T-score}"/>
          <interpretationCode code="L" codeSystem="2.16.840.1.113883.5.83" displayName="Low"/>
          <referenceRange>
            <observationRange>
              <text>-1.0 or higher is normal; -2.5 or lower is osteoporosis</text>
              <value xsi:type="IVL_PQ"><low value="-1" unit="{T-score}"/></value>
            </observationRange>
          </referenceRange>
        </observation>
      </component>
    </organizer>
  </entry>
  <entry typeCode="DRIV">
    <organizer classCode="CLUSTER" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.1" extension="2015-08-01"/>
      <id root="9e44f668-c650-44a3-86d6-ceed9db80be1"/>
      <code code="55758-7" codeSystem="2.16.840.1.113883.6.1" displayName="Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]"/>
      <statusCode code="completed"/>
      <effectiveTime><low value="20260615"/><high value="20260615"/></effectiveTime>

      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="229538d5-9de7-4dd0-9c6d-cda66ef8e3ce"/>
          <code code="55758-7" codeSystem="2.16.840.1.113883.6.1" displayName="Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]"/>
          <text><reference value="#result-28"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="20260615"/>
          <value xsi:type="PQ" value="1" unit="{score}"/>
        </observation>
      </component>
    </organizer>
  </entry>
  <entry typeCode="DRIV">
    <organizer classCode="CLUSTER" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.1" extension="2015-08-01"/>
      <id root="6ca6ea78-26f3-45ae-a188-e8183d3ebab3"/>
      <code code="72514-3" codeSystem="2.16.840.1.113883.6.1" displayName="Pain severity - 0-10 verbal numeric rating [Score] - Reported"/>
      <statusCode code="completed"/>
      <effectiveTime><low value="20260615"/><high value="20260615"/></effectiveTime>

      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="78e80dbc-7fe9-49a9-98f6-29702951bdd8"/>
          <code code="72514-3" codeSystem="2.16.840.1.113883.6.1" displayName="Pain severity - 0-10 verbal numeric rating [Score] - Reported"/>
          <text><reference value="#result-29"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="20260615"/>
          <value xsi:type="PQ" value="5" unit="{score}"/>
        </observation>
      </component>
    </organizer>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.8"/>
    <code code="51848-0" codeSystem="2.16.840.1.113883.6.1" displayName="Evaluation note"/>
    <title>Assessment</title>
    <text><list listType="ordered"><item>Prostate adenocarcinoma, Grade Group 4, cT3a N1 M1b, de novo metastatic hormone-sensitive disease, low volume (C61). The diagnosis is confirmed. By the conventional-imaging definition used in the trials and the AUA/SUO guideline, high volume means four or more bone metastases with at least one outside the spine and pelvis, or visceral metastases; he has two bone metastases, both within the spine and pelvis, and no visceral disease, so the disease is low volume. The PSMA PET/CT shows nothing more. He has symptoms from the bone metastasis in the right ilium. [S]</item><item>Systemic treatment (Z79.899). Androgen deprivation should be combined with an androgen receptor pathway inhibitor. Apalutamide, enzalutamide, darolutamide and abiraterone with prednisone are all reasonable. Apalutamide is a single daily tablet without a steroid and improved survival in low-volume disease in the TITAN trial; abiraterone needs prednisone and can worsen blood pressure and glucose, which matters with his hypertension and prediabetes. Docetaxel is not recommended: in low-volume disease it did not clearly improve survival, and triplet therapy is reserved for selected patients with high-volume disease. Apalutamide started a week before the first leuprolide injection also blocks the testosterone flare, so bicalutamide is not needed. [S]</item><item>Radiotherapy to the prostate. In low-volume metastatic disease, radiotherapy to the prostate added to androgen deprivation improved survival in STAMPEDE, and the guidelines support it in selected patients. It is recommended, about six weeks after starting androgen deprivation, as 55 Gy in 20 daily fractions. [S]</item><item>Bone health and bone metastases (M85.89). Bone-protective drugs at the monthly doses used to prevent skeletal events are recommended in castration-resistant disease; in hormone-sensitive disease, early zoledronic acid did not reduce skeletal events (CALGB 90202). His own fracture risk is the reason to treat: FRAX with androgen deprivation counted gives a hip fracture risk of 3.4 percent, above the 3 percent threshold. Denosumab 60 mg every six months, the osteoporosis dose, is recommended after a dental examination and once vitamin D replacement has begun and calcium is normal. The painful iliac metastasis is likely to settle on androgen deprivation; radiotherapy to that bone remains an option if it does not. [S]</item><item>Genetic testing. Germline testing is recommended for every patient with metastatic prostate cancer, and somatic testing of the tumor for metastatic disease; the results could change later treatment (a PARP inhibitor for a BRCA2 alteration) and would matter for his relatives. Pre-test counseling was done today. [S]</item><item>Drug interactions and hypertension (I10). Apalutamide is a strong CYP3A4 inducer and will lower amlodipine levels, so blood pressure may rise in the first weeks. It also raises the risk of rash, falls, fractures and raised TSH. [S]</item></list><paragraph>Data reviewed: Multiparametric MRI of the prostate (52 mL gland; 24 mm PI-RADS 5 right peripheral zone lesion with extraprostatic extension; 13 mm right external iliac node); MRI-targeted biopsy (Gleason 4+4, Grade Group 4, in 9 of 14 cores, all on the right, with perineural invasion); CT of the chest, abdomen and pelvis (right external iliac 13 mm and obturator 11 mm nodes; sclerotic lesions in the right iliac wing and L5 without canal narrowing; no visceral disease); bone scan (two lesions only, right ilium and L5); gallium-68 PSMA PET/CT (concordant, no further disease); the first-visit laboratory tests; and this morning&apos;s DXA (femoral neck T-score -2.1, L1 to L4 -1.4). [S]</paragraph></text>

  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.10" extension="2014-06-09"/>
    <code code="18776-5" codeSystem="2.16.840.1.113883.6.1" displayName="Plan of care note"/>
    <title>Plan of Treatment</title>
    <text><list><item>Apalutamide 240 mg once daily, starting today. [S]</item><item>Leuprolide 22.5 mg intramuscularly in one week at this clinic, then every twelve weeks, continuously. [S]</item><item>No docetaxel for low-volume disease. [S]</item><item>Radiotherapy to the prostate, 55 Gy in 20 daily fractions, about six weeks after starting androgen deprivation; radiation oncology planning in about four weeks. [S]</item><item>Germline testing sent today after counseling; somatic testing on the biopsy tissue. [S]</item><item>Bone health: cholecalciferol 2000 units daily, calcium 1000 to 1200 mg a day from food, weight-bearing and resistance exercise, a dental examination, then denosumab 60 mg every six months; DXA every one to two years. [S]</item><item>Acetaminophen for pain; same-day assessment for new leg weakness or numbness or loss of bladder or bowel control. [S]</item><item>Primary care monitoring: blood pressure at every visit, with the amlodipine dose adjusted as needed; PSA and testosterone at about four weeks and three months, then every three months; blood count and chemistry; TSH before apalutamide and every four months; hemoglobin A1c and lipids at baseline and yearly; rash, falls, hot flashes, fatigue, sexual health, mood and cognition at each visit. [S]</item><item>Report any rash early: grade 1 or 2 rash is treated with a topical steroid and an antihistamine while apalutamide continues; apalutamide is held for grade 3 rash or any blistering or mucosal involvement. [S]</item><item>Discussed with Dr. Fairweather-Diaz today. The plan was explained in Spanish through a professional interpreter, with a written summary in Spanish. Mr. Neruda chose apalutamide with leuprolide and radiotherapy to the prostate after hearing each option, including docetaxel and abiraterone, and agrees with the plan. [S]</item><item>Follow-up: Leuprolide injection here in one week. Radiation oncology planning in about four weeks. Medical oncology review at three months with PSA and testosterone, and every three months after that. Primary care sees him at four weeks for blood pressure, the early PSA and the first denosumab dose, and carries out the monitoring above between oncology visits. [S]</item></list></text>

  </section>
</component>
    </structuredBody>
  </component>
</ClinicalDocument>
